AstraZeneca

A once-daily pill could do away with needing to inject

Obesity

Weight-loss pill passes important safety trial

Game-changing GLP-1 agonist drugs are a step closer to being available in oral pill form, with AstraZeneca revealing "encouraging data" from the Phase I safety and tolerability trial of its once-daily obesity and diabetes drug AZD5004.

Researchers studied a man who received 217 COVID vaccine doses

Infectious Diseases

What happened to the guy who had 217 COVID vaccinations

A man that police caught taking 217 doses of COVID vaccine has offered himself up to researchers for a study looking into what happens to the immune system after so many doses. The results offer surprising insight into these new mRNA vaccines.

AstraZeneca has unveiled designs for its planned new HQ and R&D center in Cambridge, UK

Architecture

Design for AstraZeneca's new high-tech campus unveiled

Designs have been released for AstraZeneca's planned new corporate HQ and global R&D center in Cambridge, UK. The facility will cost around £330 million (US$560 million). Designed by Herzog & de Meuron, it will include high-tech research spaces, collaboration spaces and a green, low-energy design.